Clinical Trial Update: A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating the safety and potential efficacy of combining Zidovudine (AZT) with Interleukin-2 (IL-2) in HIV-infected patients has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED